4th Quarter - Report — PODESTA GROUP, INC. for EMD SERONO INC (2008)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm

PODESTA GROUP, INC.

Client

EMD SERONO INC

Income

$50,000

Expenses

—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
4th Quarter - Report (this page)	Jan 21, 2009	$50,000	Replaced
4th Quarter - Amendment	Jan 22, 2010	$50,000	Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H. R. 3162, Children's Health and Medicare Protection Act of 2007 H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H. R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions Comparative Effectiveness 2008 Medicare Bill H.R. 1424, Emergency Economic Stabilization Act of 2008

Lobbyist	Covered position, as disclosed
DANIELE BAIERLEIN	—
SHARON COHEN	—
ANTHONY PODESTA	—
NICOLE C YOUNG New	—

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE; Patent & Trademark Office (PTO)

Bills named: H.R. 1424 (110th), S. 2662 (110th), S. 3 (110th), H.R. 2606 (110th), S. 1376 (110th), H.R. 4 (110th), H.R. 5480 (110th), H.R. 3162 (110th), S. 2029 (110th)

Pharmacy PHA

S. 877, Controlling the Abuse of Prescriptions Act of 2007 Drug importation H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H. R. 5629, Pathway for Biosimilars Act S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 623, Access to Life-Saving Medicine Act, follow-on biologics

Lobbyist	Covered position, as disclosed
PAUL BRATHWAITE	Exec. Dir., Congressional Black Caucus
SHARON COHEN	—
COURTNEY HAGEN	—
ANDREW KAUDERS	Sr. Adv. Sen. Menendez; ED, House Demo Caucus
ANTHONY PODESTA	—
NICOLE C YOUNG New	—

Contacted: SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS)

Bills named: S. 877 (110th), H.R. 1038 (110th), S. 1695 (110th), H.R. 5629 (110th), S. 1505 (110th), S. 2029 (110th), S. 623 (110th), H.R. 1956 (110th)

Budget/Appropriations BUD

LHHS Appropriations Drug importation House Concurrent Resolution 312 House Budget Resolution Senate Concurrent Resolution 70 Senate Budget Resolution Comparative Effectiveness

Lobbyist	Covered position, as disclosed
SHARON COHEN	—
RANDALL GERARD	—
ANTHONY PODESTA	—
NICOLE C YOUNG New	—

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Food & Drug Administration (FDA)

Copyright/Patent/Trademark CPT

S. 1145, Patent Reform Act of 2007, entire bill S. 3600, Patent Reform Act of 2008 H. R. 1908, Patent Reform Act of 2007, entire bill

Lobbyist	Covered position, as disclosed
SHARON COHEN	—
COURTNEY HAGEN	—
CLAUDIA JAMES	—
ANTHONY PODESTA	—
NICOLE C YOUNG New	—

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); SENATE; Patent & Trademark Office (PTO)

Bills named: S. 1145 (110th), S. 3600 (110th), H.R. 1908 (110th)

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

Entity	Country	Principal place of business	Ownership	Contribution declared
MERCK SERONO S.A.	Germany	Germany	100.0%	—

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.